BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
US Department of Justice
AstraZeneca
Cerilliant
Deloitte
Moodys
Federal Trade Commission
US Army
Farmers Insurance

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080680

« Back to Dashboard

NDA 080680 describes FOLIC ACID, which is a drug marketed by Ben Venue, Fresenius Kabi Usa, Aiping Pharm Inc, Amneal Pharm, Barr, Cadila Pharms Ltd, Contract Pharmacal, Everylife, Halsey, Hikma Pharms, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Jubilant Cadista, Lannett, Leading Pharma Llc, Lilly, Mk Labs, Nexgen Pharma Inc, Nuvo Pharm Inc, Pharmeral, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Tablicaps, UDL, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage, Vintage Pharms, Watson Labs, and Whiteworth Town Plsn, and is included in thirty-six NDAs. It is available from thirty-nine suppliers. Additional details are available on the FOLIC ACID profile page.

The generic ingredient in FOLIC ACID is folic acid. There are nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the folic acid profile page.
Summary for 080680
Tradename:FOLIC ACID
Applicant:Watson Labs
Ingredient:folic acid
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 080680
Suppliers and Packaging for NDA: 080680
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOLIC ACID folic acid TABLET;ORAL 080680 NDA Apace Packaging 15338-170 15338-170-00 48 BOTTLE in 1 CARTON (15338-170-00) > 100 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Novartis
Citi
QuintilesIMS
McKesson
Colorcon
Accenture
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot